Add Yahoo as a preferred source to see more of our stories on Google. Lenacapavir is now approved to prevent HIV infection as well as to treat certain infections. - Gilead Sciences Inc. A drug ...

South Africa is preparing to launch the rollout of the HIV prevention injection lenacapavir in the coming weeks. The drug is one of the most talked-about advances in HIV prevention in decades. But ...

Researchers at Karolinska Institutet, in collaboration with colleagues at The Scripps Research Institute and Emory University ...

Add Yahoo as a preferred source to see more of our stories on Google. The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV. The drug, ...

A drug used to treat HIV infections can also effectively prevent them, a new clinical trial demonstrates. Image credit: luza studios/Getty Images. Human immunodeficiency virus (HIV) affects a person’s ...

By Deena Beasley May 5 (Reuters) - Use of Gilead Sciences' Yeztugo, a twice-yearly injection to prevent HIV infection, has ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A brand new drug might be more effective at preventing HIV than current ...

In the long battle to create an effective HIV vaccine, scientists have made a major leap forward. A new study shows that a series of vaccines can coax the immune system to produce powerful antibodies ...

Gilead’s Tomas Cihlar and his team of researchers have spent decades studying HIV—and their latest innovation could be a game changer for prevention.

Doctors at DAP Health have begun administering a new twice-a-year injectable HIV prevention medication, which was approved by the Food and Drug Administration in June. Gilead's drug lenacapavir ...

Kwara State introduces a free, twice-yearly anti-HIV injection, Lenacapavir, to strengthen HIV prevention and reduce new ...

The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV. The drug, called Yeztugo from company Gilead Sciences, was approved Wednesday based ...